SCHEMBL5492374

SCHEMBL5492374

CC1(C)OB(c2cccc3c2CN(C(=O)O)CC3)OC1(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.38
ABHD6 Q9BV23 2/20 0.37
ROCK1 Q13464 1/20 0.37
TMEM97 Q5BJF2 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
HRH3 Q9Y5N1 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
MAPT P10636 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
TP53 P04637 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 2/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2C9 P11712 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15272805 0.90 ABHD6 (0.41) NOTUMABHD6ROCK1MEN1KMT2A
SCHEMBL4554909 0.88 ROCK1 (0.41) NOTUMABHD6ROCK1HRH3
SCHEMBL14677886 0.86 ABHD6 (0.44) NOTUMABHD6ROCK1
SCHEMBL587257 0.84 ESR2 (0.46) ABHD6TMEM97SIGMAR1MAPT
SCHEMBL31428727 0.80 NOTUM (0.50) NOTUMABHD6ROCK1MEN1KMT2A
SCHEMBL4518196 0.80 NOTUM (0.50) NOTUMABHD6ROCK1MEN1KMT2A
SCHEMBL18524347 0.79 PTGDR2 (0.39) ROCK1PTGDR2HTR5A
SCHEMBL28849175 0.79 ROCK1 (0.33) ROCK1
SCHEMBL19949283 0.78 ABHD6 (0.37) NOTUMABHD6KMT2ANPC1KDM4E
SCHEMBL16101023 0.77 ROCK1 (0.39) ABHD6ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1831199-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2007-09-12 EP disclosed
WO-2006065215-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2006-06-22 WO disclosed